ACAD9

UniProt ID: Q9H845
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

ACAD9 (Complex I assembly factor ACAD9, mitochondrial) is a dual-function protein that serves as both a mitochondrial respiratory chain Complex I (CI) assembly factor and an acyl-CoA dehydrogenase enzyme. Its primary physiological role is as a core component of the mitochondrial complex I intermediate assembly (MCIA) complex, where it partners with ECSIT and NDUFAF1 to mediate assembly of the ND2 membrane-arm module of CI. ECSIT binding triggers a conformational change and deflavination of ACAD9, switching it from an FAO enzyme to a CI assembly factor. As a secondary/moonlighting function, ACAD9 retains FAD-dependent acyl-CoA dehydrogenase activity toward long-chain (and some medium-chain) fatty acyl-CoA substrates (EC 1.3.8.7, 1.3.8.8), catalyzing the first step of mitochondrial fatty acid beta-oxidation. Disease-causing mutations in ACAD9 result in isolated CI deficiency (MC1DN20), not primary fatty acid oxidation defects, underscoring the primacy of its assembly role. ACAD9 is a homodimer localized to the matrix side of the mitochondrial inner membrane.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0003995 acyl-CoA dehydrogenase activity
IBA
GO_REF:0000033
ACCEPT
Summary: ACAD9 is a bona fide acyl-CoA dehydrogenase, belonging to the ACAD family and retaining catalytic activity for the alpha,beta-dehydrogenation of fatty acyl-CoA substrates. The IBA annotation is phylogenetically inferred and well-supported by direct biochemical data from multiple publications (PMID:16020546, PMID:34646991, PMID:38086790). This is an appropriate level of specificity for the IBA evidence code.
Reason: ACAD9 has experimentally demonstrated acyl-CoA dehydrogenase activity. Purified ACAD9 shows dehydrogenation activity of 83 min-1 with palmitoyl-CoA as substrate (PMID:34646991). The IBA annotation at the general acyl-CoA dehydrogenase level is appropriate given phylogenetic support across the ACAD family.
Supporting Evidence:
PMID:34646991
As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0003995 acyl-CoA dehydrogenase activity
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation based on InterPro domain mapping. ACAD9 contains the acyl-CoA dehydrogenase active site signature (IPR006089) which correctly predicts this enzymatic activity. Consistent with direct experimental evidence.
Reason: The InterPro-based IEA annotation is correct and consistent with experimental data showing ACAD9 possesses acyl-CoA dehydrogenase activity (PMID:16020546, PMID:34646991). This is a broader annotation that is subsumed by the IBA and IDA annotations but not incorrect.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
GO:0004466 long-chain fatty acyl-CoA dehydrogenase activity
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation from ARBA/Rhea mapping based on the EC 1.3.8.8 catalytic activity. ACAD9 does have demonstrated long-chain acyl-CoA dehydrogenase activity (PMID:16020546), making this a valid annotation.
Reason: ACAD9 has experimentally demonstrated long-chain fatty acyl-CoA dehydrogenase activity with substrate preference for C16-C22 chain lengths (PMID:16020546). The IEA annotation correctly captures this function and is consistent with the IDA annotation from BHF-UCL.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0005743 mitochondrial inner membrane
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. ACAD9 is experimentally localized to the mitochondrial inner membrane, matrix side, as a peripheral membrane protein (PMID:16020546, PMID:20816094).
Reason: Multiple experimental studies confirm ACAD9 localizes to the mitochondrial inner membrane. Submitochondrial fractionation showed ACAD9 is membrane-associated (PMID:16020546). The UniProt entry explicitly states "Mitochondrion inner membrane; Peripheral membrane protein; Matrix side" with evidence from PMID:16020546 and PMID:20816094.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0006631 fatty acid metabolic process
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation from ARBA. ACAD9 participates in fatty acid beta-oxidation by catalyzing the first step of the FAO cycle. This is a broad term and while accurate, more specific terms (long-chain fatty acid metabolic process, GO:0001676) are already annotated.
Reason: ACAD9 does participate in fatty acid metabolism through its acyl-CoA dehydrogenase activity. While this IEA term is broader than the IDA annotation to GO:0001676, it is not incorrect and is an expected consequence of the ARBA mapping.
Supporting Evidence:
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids
GO:0016491 oxidoreductase activity
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation based on UniProtKB keyword mapping (KW-0560, Oxidoreductase). ACAD9 is indeed an oxidoreductase. This is a very general term but is not incorrect for an IEA.
Reason: ACAD9 is an oxidoreductase (acyl-CoA dehydrogenase, EC 1.3.8.7/1.3.8.8). While this is a very broad parent term, it is correctly applied via keyword mapping and more specific child terms are also annotated.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation based on InterPro domain mapping. ACAD9 catalyzes alpha,beta-dehydrogenation of fatty acyl-CoA, which is an oxidoreductase reaction acting on CH-CH groups. This is a correct intermediate-level term between general oxidoreductase and specific acyl-CoA dehydrogenase activity.
Reason: The acyl-CoA dehydrogenase reaction catalyzed by ACAD9 involves oxidation of the CH-CH bond at the alpha-beta position of fatty acyl-CoA substrates. This InterPro-derived term is accurate and at an appropriate level of specificity for automated annotation.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
GO:0031966 mitochondrial membrane
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation from ARBA. ACAD9 is localized to the mitochondrial inner membrane. This term is broader (parent) than the more specific mitochondrial inner membrane annotations also present, but is not incorrect.
Reason: ACAD9 is experimentally localized to the mitochondrial membrane (specifically the inner membrane). This broader IEA term is subsumed by more specific annotations but remains valid.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0050660 flavin adenine dinucleotide binding
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation based on InterPro domain mapping. ACAD9 is a FAD-containing flavoprotein. FAD binding has been experimentally demonstrated, with approximately 70% FAD occupancy in purified protein (PMID:34646991). FAD binding is essential for the dehydrogenase function, and ECSIT binding causes deflavination (PMID:33320993, PMID:38086790).
Reason: ACAD9 binds FAD as a cofactor for its acyl-CoA dehydrogenase activity. The FAD content of purified ACAD9 is approximately 70% (PMID:34646991), and ECSIT-mediated deflavination switches ACAD9 from FAO enzyme to CI assembly factor (PMID:33320993).
Supporting Evidence:
PMID:34646991
the FAD content of purified wild type ACAD9 protein (non-tagged ACAD9 and ACAD9-His6) was approximately 70%
PMID:33320993
interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site
GO:0070991 medium-chain fatty acyl-CoA dehydrogenase activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: IEA annotation from ARBA/Rhea mapping based on EC 1.3.8.7. ACAD9 does have some activity toward medium-chain substrates (C9-C11-CoA) as demonstrated in PMID:16020546. However, its primary specificity is for long-chain substrates; medium-chain activity is lower and secondary.
Reason: While ACAD9 is primarily a long-chain ACAD, it does have experimentally demonstrated medium-chain activity (PMID:16020546), and this is consistent with the EC 1.3.8.7 assignment in UniProt. The IEA annotation correctly reflects the catalogued EC number.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0017099 very-long-chain fatty acyl-CoA dehydrogenase activity
IDA
PMID:33320993
Assembly of The Mitochondrial Complex I Assembly Complex Sug...
MODIFY
Summary: IDA annotation from FlyBase based on Giachin et al. 2021, which characterized ACAD9 acyl-CoA dehydrogenase activity using an ETF fluorescence reduction assay with palmitoyl-CoA (C16:0) as substrate. While ACAD9 does have dehydrogenase activity, the term "very-long-chain" (GO:0017099, typically C20+) may be an over-annotation. ACAD9's primary substrates are long-chain (C14-C18), not very-long-chain. The activity measured in this paper used palmitoyl-CoA (C16:0), which is a long-chain substrate.
Reason: ACAD9 has optimal activity with long-chain (C14-C18) substrates, not very-long-chain (C20+). The paper PMID:33320993 demonstrated ACAD dehydrogenase activity using palmitoyl-CoA (C16:0), which is a long-chain substrate. While ACAD9 does have some activity on C20:0 (eicosanoyl-CoA) as shown in PMID:16020546, its primary specificity is long-chain. The annotation should be modified to long-chain fatty acyl-CoA dehydrogenase activity (GO:0004466).
Supporting Evidence:
PMID:33320993
After addition of the ACAD specific substrate palmitoyl-CoA (C16:0), there is a clear loss of ETF fluorescence in ACAD9 alone
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0017099 very-long-chain fatty acyl-CoA dehydrogenase activity
IDA
PMID:34646991
Molecular mechanism of interactions between ACAD9 and bindin...
MODIFY
Summary: IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This paper characterized ACAD9 enzymatic activity using palmitoyl-CoA (C16:0) as substrate and measured dehydrogenation activity of 83 min-1. The activity is real but the term "very-long-chain" is an overstatement of specificity, since palmitoyl-CoA is a long-chain substrate.
Reason: Same reasoning as above. ACAD9 has its optimal activity on long-chain substrates (C14-C18). The paper PMID:34646991 used palmitoyl-CoA (C16:0) as substrate, which is long-chain. The VLCAD-like annotation is misleading; ACAD9 activity is only 18% of VLCAD activity (PMID:34646991).
Supporting Evidence:
PMID:34646991
this activity is only 18% of VLCAD activity
PMID:34646991
As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein
GO:0030674 protein-macromolecule adaptor activity
IDA
PMID:32320651
Dissecting the Roles of Mitochondrial Complex I Intermediate...
ACCEPT
Summary: IDA annotation from FlyBase based on Formosa et al. 2020, which demonstrated that ACAD9 is a core component of the MCIA complex and acts as an adaptor linking ECSIT (and through it, NDUFAF1) to CI assembly intermediates. The study showed ACAD9 forms a hierarchy of stability centered on itself within the MCIA complex. This is an excellent annotation capturing ACAD9's primary assembly factor role using a molecular function term.
Reason: ACAD9 functions as a protein-macromolecule adaptor within the MCIA complex, bridging ECSIT to CI assembly intermediates. This is well-supported by PMID:32320651, which showed that knockout of ACAD9 destabilizes the entire MCIA complex, and by structural studies showing ACAD9 provides binding surfaces for ECSIT via its vestigial dehydrogenase domain (PMID:33320993, PMID:38086790). This annotation captures the core molecular function of ACAD9 in CI assembly.
Supporting Evidence:
PMID:32320651
while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9
PMID:33320993
ECSIT functions as the bridging node of the MCIA core complex
GO:0160295 mitochondrial complex I intermediate assembly complex
IDA
PMID:33320993
Assembly of The Mitochondrial Complex I Assembly Complex Sug...
ACCEPT
Summary: IDA annotation from FlyBase based on Giachin et al. 2021. This study provided extensive structural and biochemical evidence that ACAD9 is a core component of the MCIA complex, including cryo-EM structures, SAXS, native MS, and SEC-MALLS data demonstrating stable ACAD9-ECSIT complexes.
Reason: ACAD9 is unequivocally a component of the MCIA complex. Giachin et al. demonstrated formation of the ACAD9-ECSIT binary complex by multiple biophysical methods and showed ECSIT binds the vestigial dehydrogenase domain of ACAD9 (PMID:33320993). This is a core annotation for ACAD9.
Supporting Evidence:
PMID:33320993
ECSIT functions as the bridging node of the MCIA core complex
PMID:33320993
the C-terminal domain of ECSIT directly binds to the vestigial dehydrogenase domain of the FAO enzyme ACAD9 and induces its deflavination
GO:0160295 mitochondrial complex I intermediate assembly complex
IDA
PMID:34646991
Molecular mechanism of interactions between ACAD9 and bindin...
ACCEPT
Summary: IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This study reconstituted the ACAD9/ECSIT/NDUFAF1 ternary complex in vitro and characterized it by SEC, SAXS, and pull-down assays, demonstrating ACAD9 is a core member of the MCIA complex.
Reason: Xia et al. provided direct biochemical evidence for ACAD9 as part of the MCIA ternary complex with ECSIT and NDUFAF1, including purification of the stable ternary complex with 1:1:1 stoichiometry (PMID:34646991). This is strong supporting evidence for the CC annotation.
Supporting Evidence:
PMID:34646991
ACAD9, ECSIT, and NDUFAF1 form the core mitochondrial CI assembly (MCIA) complex
PMID:34646991
mixing of the three purified, individual proteins forms a ternary complex, ACAD9/ECSIT/NDUFAF1, with a 1:1:1 molar (monomer) ratio
GO:0005739 mitochondrion
IDA
GO_REF:0000052
ACCEPT
Summary: IDA annotation from HPA based on immunofluorescence data. ACAD9 localization to mitochondria is well-established across multiple studies and methods.
Reason: ACAD9 mitochondrial localization is confirmed by multiple independent approaches: submitochondrial fractionation (PMID:16020546), immunofluorescence (PMID:20816094), and proteomics (PMID:34800366). The HPA immunofluorescence data is consistent with this body of evidence.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0160295 mitochondrial complex I intermediate assembly complex
IDA
PMID:32320651
Dissecting the Roles of Mitochondrial Complex I Intermediate...
ACCEPT
Summary: IDA annotation from FlyBase based on Formosa et al. 2020. This study used cell knockout studies of each MCIA component and demonstrated that ACAD9 is central to MCIA complex stability, also identifying TMEM186 and COA1 as additional MCIA components.
Reason: Formosa et al. provided strong genetic evidence from knockout studies that ACAD9 is a core component of the MCIA complex, with a central role in maintaining complex stability. Loss of ACAD9 resulted in destabilization of the entire MCIA complex and impaired CI assembly (PMID:32320651).
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
PMID:32320651
while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9
GO:0003995 acyl-CoA dehydrogenase activity
IDA
PMID:38086790
The assembly of the Mitochondrial Complex I Assembly complex...
ACCEPT
Summary: IDA annotation from FlyBase based on McGregor et al. 2023 (Nature Communications). This study determined a 3.0 A cryo-EM structure of the ACAD9-ECSIT complex and also characterized ACAD9 dehydrogenase activity using the ETF fluorescence reduction assay with palmitoyl-CoA. The study demonstrated ECSIT binding induces a large conformational change in the FAD-binding loop of ACAD9, releasing FAD and converting ACAD9 from an FAO enzyme to a CI assembly factor.
Reason: McGregor et al. directly measured ACAD9 acyl-CoA dehydrogenase activity via ETF fluorescence reduction assay and confirmed the deflavination mechanism (PMID:38086790). This provides direct experimental evidence for ACAD9's enzymatic function.
Supporting Evidence:
PMID:38086790
ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor
GO:0005743 mitochondrial inner membrane
NAS
PMID:32320651
Dissecting the Roles of Mitochondrial Complex I Intermediate...
ACCEPT
Summary: NAS annotation from ComplexPortal based on PMID:32320651. ACAD9 functions as part of the MCIA complex at the mitochondrial inner membrane where CI assembly occurs. This is consistent with the experimentally determined localization.
Reason: ACAD9 is localized to the mitochondrial inner membrane, matrix side, as a peripheral membrane protein. This is well-supported by fractionation studies (PMID:16020546) and is the site of its CI assembly function as part of the MCIA complex (PMID:32320651).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0032981 mitochondrial respiratory chain complex I assembly
NAS
PMID:32320651
Dissecting the Roles of Mitochondrial Complex I Intermediate...
ACCEPT
Summary: NAS annotation from ComplexPortal based on Formosa et al. 2020. ACAD9 is essential for CI assembly as a core member of the MCIA complex. This is the primary biological process annotation for ACAD9 and represents its most important physiological function.
Reason: CI assembly is the primary biological process function of ACAD9. Multiple studies demonstrate that loss of ACAD9 causes isolated CI deficiency (PMID:20816094), ACAD9 is part of the MCIA complex required for ND2-module assembly (PMID:32320651), and disease mutations cluster in the assembly domain (PMID:20816094).
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
file:human/ACAD9/ACAD9-deep-research-falcon.md
its dominant essential role is as a CI assembly factor within MCIA.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: HTP annotation from high-throughput human mitochondrial proteome study (Morgenstern et al. 2021). ACAD9 was identified as a high-confidence mitochondrial protein. This is consistent with extensive prior evidence.
Reason: ACAD9 is a well-established mitochondrial protein. Its identification in a quantitative high-confidence mitochondrial proteome study (PMID:34800366) adds further confirmation to established knowledge from targeted studies (PMID:16020546, PMID:20816094).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005515 protein binding
IPI
PMID:33753518
TMEM70 and TMEM242 help to assemble the rotor ring of human ...
MARK AS OVER ANNOTATED
Summary: IPI annotation based on Carroll et al. 2021, which showed TMEM70 and TMEM242 interact with MCIA complex components including ACAD9. The WITH field includes UniProtKB:Q8IUX1 (TMEM242), Q9BQ95 (TMEM126B), Q9BUB7 (TMEM70), and Q9Y375 (NDUFAF1). While the interactions are real and informative, the term 'protein binding' is uninformative. The adaptor activity annotation (GO:0030674) already captures the functionally relevant aspect.
Reason: The protein binding term is uninformative. The ACAD9 interactions with TMEM70 and TMEM242 are real (PMID:33753518), but this function is better captured by the protein-macromolecule adaptor activity annotation (GO:0030674) and the MCIA complex membership (GO:0160295). Generic 'protein binding' does not tell us anything about the actual function of ACAD9.
Supporting Evidence:
PMID:33753518
TMEM70 and TMEM242 interact with the mitochondrial complex I assembly (the MCIA) complex that supports assembly of the membrane arm of complex I
GO:0005515 protein binding
IPI
PMID:32320651
Dissecting the Roles of Mitochondrial Complex I Intermediate...
MARK AS OVER ANNOTATED
Summary: IPI annotation based on Formosa et al. 2020. The WITH field includes TMEM126B (Q96B77), ECSIT (Q9BQ95), TMEM186 (Q9GZY4), and NDUFAF1 (Q9Y375). These are the MCIA complex interactions. While real, 'protein binding' is uninformative.
Reason: Same as above. The interactions with MCIA complex components are real and well-characterized (PMID:32320651), but 'protein binding' is uninformative. The adaptor activity (GO:0030674) and MCIA complex membership (GO:0160295) annotations are more informative.
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
GO:0001676 long-chain fatty acid metabolic process
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
KEEP AS NON CORE
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 participates in long-chain fatty acid beta-oxidation, with maximal activity toward long-chain unsaturated acyl-CoA substrates (C16:1, C18:1, C18:2, C22:6). This is a secondary/moonlighting function but is experimentally well-supported.
Reason: While ACAD9 does participate in long-chain fatty acid metabolism, this represents a secondary/moonlighting function. The primary in vivo role is CI assembly (PMID:20816094). Disease mutations cause CI deficiency rather than primary FAO defects (PMID:20816094). However, FAO activity is tissue-relevant especially in brain where ACAD9 is the main long-chain ACAD (PMID:16020546, PMID:17564966).
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
PMID:20816094
ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation
GO:0004466 long-chain fatty acyl-CoA dehydrogenase activity
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
ACCEPT
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 was purified, expressed, and its substrate utilization pattern characterized, demonstrating maximal activity with long-chain (C16-C18) unsaturated acyl-CoA substrates. This is the most appropriate specific MF term for ACAD9's enzymatic activity.
Reason: ACAD9 has well-characterized long-chain acyl-CoA dehydrogenase activity with Km values of 2.8 uM for hexadecanoyl-CoA and 0.7 uM for (9Z)-hexadecenoyl-CoA (PMID:16020546). This is the correct level of specificity for ACAD9's enzymatic function.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0005739 mitochondrion
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
ACCEPT
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation studies confirmed ACAD9 is associated with the mitochondrial membrane.
Reason: Direct experimental evidence from submitochondrial fractionation demonstrates ACAD9 is a mitochondrial protein associated with mitochondrial membranes (PMID:16020546).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0031966 mitochondrial membrane
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
ACCEPT
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation showed ACAD9 is membrane-associated. This is less specific than the inner membrane annotation but still correct based on the fractionation data.
Reason: ACAD9 is a peripheral membrane protein associated with the mitochondrial inner membrane on the matrix side (PMID:16020546). The mitochondrial membrane annotation is correct, though the more specific inner membrane annotation is also present.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0051791 medium-chain fatty acid metabolic process
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
KEEP AS NON CORE
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows some activity toward medium-chain substrates (C9-C11-CoA) in addition to its primary long-chain specificity. This is a secondary activity.
Reason: ACAD9 does have some medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), but its primary enzymatic specificity is for long-chain substrates, and its primary biological role is CI assembly. Medium-chain FAO is a minor secondary activity, better handled by MCAD in vivo.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0070991 medium-chain fatty acyl-CoA dehydrogenase activity
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
KEEP AS NON CORE
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows activity toward some medium-chain substrates in the C9-C11 range. While less active than on long-chain substrates, this has been directly demonstrated experimentally.
Reason: ACAD9 does have demonstrable medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), though this is secondary to its long-chain specificity and far secondary to its CI assembly role. The activity is real but minor compared to dedicated MCAD.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-6799179
ACCEPT
Summary: TAS annotation from Reactome pathway "Peripheral arm subunits bind the 815kDa complex to form a 980kDa complex". ACAD9 functions at the mitochondrial inner membrane as part of the MCIA complex during CI biogenesis.
Reason: ACAD9 is localized to the mitochondrial inner membrane where CI assembly takes place. This is well-supported experimentally (PMID:16020546, PMID:20816094) and the Reactome annotation correctly reflects this.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-6799196
ACCEPT
Summary: TAS annotation from Reactome pathway "The MCIA complex, NDUFAF2-7 all dissociate from the 980kDa complex, resulting in Complex I". Consistent with ACAD9's role as an MCIA assembly factor at the inner membrane.
Reason: Same as above. ACAD9 is at the mitochondrial inner membrane and this Reactome step describes MCIA complex dissociation after CI assembly is complete. Well-supported experimentally.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-6799197
ACCEPT
Summary: TAS annotation from Reactome pathway "ND4, ND5 bind the 550kDa complex to form the 815kDa complex". Another step in CI biogenesis at the inner membrane.
Reason: Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-6799199
ACCEPT
Summary: TAS annotation from Reactome pathway "COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind the MCIA complex to form a 370kDa subcomplex". This step directly involves the MCIA complex of which ACAD9 is a core member.
Reason: ACAD9 is a core member of the MCIA complex that participates in this assembly step. Well-supported by PMID:32320651.
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-6799202
ACCEPT
Summary: TAS annotation from Reactome pathway "The 315kDa subcomplex binds the 370kDa subcomplex to form the 550kDa complex". Another CI assembly step at the inner membrane.
Reason: Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005515 protein binding
IPI
PMID:20816094
Acyl-CoA dehydrogenase 9 is required for the biogenesis of o...
MARK AS OVER ANNOTATED
Summary: IPI annotation based on Nouws et al. 2010, which showed ACAD9 interacts with NDUFAF1 (Q9Y375) and ECSIT (Q9BQ95). These are the foundational interactions establishing ACAD9 as an MCIA complex member. However, 'protein binding' is uninformative.
Reason: The interactions demonstrated by Nouws et al. (PMID:20816094) are central to understanding ACAD9's CI assembly function, but the generic 'protein binding' term fails to capture the biological significance. The adaptor activity (GO:0030674) and MCIA complex membership (GO:0160295) annotations are far more informative.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
GO:0005739 mitochondrion
IDA
PMID:20816094
Acyl-CoA dehydrogenase 9 is required for the biogenesis of o...
ACCEPT
Summary: IDA annotation based on Nouws et al. 2010. ACAD9 was shown to localize to mitochondria as part of the study establishing its role in CI assembly.
Reason: ACAD9 mitochondrial localization is well-established and confirmed in this study (PMID:20816094) which demonstrated ACAD9 interactions with mitochondrial CI assembly factors.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
GO:0032981 mitochondrial respiratory chain complex I assembly
IMP
PMID:20816094
Acyl-CoA dehydrogenase 9 is required for the biogenesis of o...
ACCEPT
Summary: IMP annotation based on Nouws et al. 2010. This landmark study demonstrated that ACAD9 mutations result in CI deficiency (not FAO deficiency), establishing CI assembly as ACAD9's primary function. ACAD9 knockdown/mutation leads to impaired CI assembly. This is the strongest evidence for ACAD9's primary biological process.
Reason: Nouws et al. provided the foundational evidence that ACAD9 is required for CI biogenesis, showing that ACAD9 mutations cause CI deficiency rather than FAO defects, and that ACAD9 interacts with known CI assembly factors NDUFAF1 and ECSIT (PMID:20816094). This IMP annotation is the most critical biological process annotation for ACAD9.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
PMID:20816094
ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation
GO:0005634 nucleus
IDA
PMID:21237683
Identification and characterization of new long chain acyl-C...
REMOVE
Summary: IDA annotation based on He et al. 2011. This study characterized new long-chain ACADs including ACAD9, ACAD10, and ACAD11, and reported ACAD9 in the nucleus. However, ACAD9 is a mitochondrial protein with a mitochondrial transit peptide, and all functional studies place it in mitochondria. Nuclear localization is likely an artifact of overexpression or immunostaining cross-reactivity and is not supported by the consensus of literature.
Reason: ACAD9 has a mitochondrial transit peptide (residues 1-37, cleaved upon import; PMID:16020546) and all functional characterization places it in mitochondria. The nuclear localization reported in PMID:21237683 is not supported by other studies and is likely artifactual. UniProt does not include nuclear localization. The extensive proteomics and fractionation data consistently place ACAD9 in mitochondria only.
Supporting Evidence:
PMID:16020546
A 37-amino acid leader peptide was cleaved sequentially by two mitochondrial peptidases to yield a predicted molecular mass of 65 kDa for the mature subunit
GO:0030425 dendrite
IDA
PMID:21237683
Identification and characterization of new long chain acyl-C...
REMOVE
Summary: IDA annotation based on He et al. 2011. The study examined ACAD expression patterns in human cerebellum and found ACAD9 was highly expressed in the granular layer. The dendrite annotation likely reflects immunohistochemical staining of neuronal processes. However, this is a cell-type expression pattern rather than a specific subcellular localization to dendrites. The protein within those cells is still in mitochondria.
Reason: ACAD9 is a mitochondrial matrix-facing protein. Finding it in neurons (including dendritic processes) reflects tissue expression (ACAD9 is highly expressed in cerebellum) rather than specific dendritic localization. The protein is in mitochondria within dendrites, not in the dendritic cytoplasm. This annotation conflates cell-type expression with subcellular localization.
Supporting Evidence:
PMID:21237683
ACAD9 was most highly expressed in the granular layer
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0005739 mitochondrion
IDA
GO_REF:0000054
ACCEPT
Summary: IDA annotation from LIFEdb based on expressed fusion protein localization in living cells. ACAD9 localization to mitochondria was confirmed, consistent with all other evidence.
Reason: ACAD9 mitochondrial localization is well-established. The LIFEdb fusion protein experiment confirms what is known from multiple other approaches (PMID:16020546, PMID:20816094, PMID:34800366).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
GO:0006635 fatty acid beta-oxidation
IDA
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mit...
NEW
Summary: ACAD9 catalyzes the first step of mitochondrial fatty acid beta-oxidation, the alpha,beta-dehydrogenation of long-chain fatty acyl-CoA substrates. This specific biological process term is not currently annotated but is more precise than the existing GO:0006631 (fatty acid metabolic process) and GO:0001676 (long-chain fatty acid metabolic process) annotations.
Reason: ACAD9 directly catalyzes the first step of the beta-oxidation cycle. The existing BP annotations (GO:0006631 fatty acid metabolic process, GO:0001676 long-chain fatty acid metabolic process) are correct but the more specific fatty acid beta-oxidation term is warranted given the direct experimental evidence. This is ACAD9's secondary core function.
Supporting Evidence:
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids
PMID:34646991
ACAD9 was first identified as a member of the acyl-CoA dehydrogenase family catalyzing the alpha, beta-dehydrogenation of fatty acyl-CoA thioesters, the first step of the fatty acid beta-oxidation cycle

Core Functions

Primary function. ACAD9 is a core component of the MCIA complex, functioning as a protein-macromolecule adaptor that bridges ECSIT (and through ECSIT, NDUFAF1) to CI assembly intermediates. ECSIT binding triggers deflavination and a conformational switch from FAO enzyme to assembly factor. Disease mutations causing CI deficiency (MC1DN20) underscore this as the essential role.

Supporting Evidence:
  • PMID:20816094
    ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
  • PMID:32320651
    while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9
  • PMID:38086790
    ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor

Secondary/moonlighting function. ACAD9 retains FAD-dependent acyl-CoA dehydrogenase activity (EC 1.3.8.8) toward long-chain fatty acyl-CoA substrates, catalyzing the first step of mitochondrial fatty acid beta-oxidation. Its activity is approximately 18% that of VLCAD. This function is mutually exclusive with the CI assembly role (ECSIT binding causes deflavination). ACAD9's FAO role is particularly relevant in tissues where it is the main long-chain ACAD, such as the CNS.

Supporting Evidence:
  • PMID:16020546
    Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
  • PMID:34646991
    this activity is only 18% of VLCAD activity

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Gene Ontology annotation based on curation of intracellular localizations of expressed fusion proteins in living cells
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids.
  • ACAD9 is a mitochondrial membrane-associated homodimer with long-chain acyl-CoA dehydrogenase activity, maximal toward unsaturated C16-C22 substrates.
    "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)."
Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.
  • ACAD9 binds CI assembly factors NDUFAF1 and ECSIT and is specifically required for CI assembly. ACAD9 mutations cause CI deficiency, not FAO defects.
    "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation."
Identification and characterization of new long chain acyl-CoA dehydrogenases.
  • ACAD9 is highly expressed in human cerebellum (granular layer), where ACADV is not found, suggesting tissue-specific roles in long-chain FAO.
    "ACAD9 was most highly expressed in the granular layer, ACAD11 in the white matter, and MCAD in the molecular layer and axons of specific neurons."
ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies.
  • The CI assembly function of ACAD9 is independent of its FAO activity. The E426Q catalytic mutant abolishes dehydrogenase activity but does not affect CI assembly.
    "Catalytically inactive ACAD9 gave partial-to-complete rescue of complex I biogenesis in ACAD9-deficient cells"
Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly Complex Factors in the Biogenesis of Complex I.
  • ACAD9 is a core member of the MCIA complex (with NDUFAF1, ECSIT, TMEM126B) required for ND2-module assembly. A hierarchy of stability exists centered on ACAD9. TMEM186 and COA1 are additional MCIA components.
    "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9."
Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for Deflavination.
  • ECSIT C-terminal domain binds the vestigial dehydrogenase domain of ACAD9 and induces deflavination, switching ACAD9 from an FAO enzyme to a CI assembly factor. Cryo-EM confirmed the FAD binding site is empty in the ECSIT-bound state.
    "interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site."
TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase and interact with assembly factors for complex I.
  • TMEM70 and TMEM242 interact with MCIA complex components including ACAD9, ECSIT, NDUFAF1, and TMEM126B.
    "When TMEM242-t and similarly tagged TMEM70 (TMEM70-t) were expressed separately in HEK293 cells, the most significantly associated proteins were ACAD9 (acyl-CoA dehydrogenase family member 9), ECSIT (evolutionarily conserved signaling intermediate in Toll pathway), and NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1)"
Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial respiratory complex I assembly.
  • ACAD9, ECSIT, and NDUFAF1 form a stable 1:1:1 ternary complex. ECSIT binds at the ETF binding site in ACAD9's N-terminal domain, explaining the mutual exclusivity of FAO and assembly functions. ACAD9 activity is only 18% of VLCAD.
    "this activity is only 18% of VLCAD activity"
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
  • ACAD9 was identified as a high-confidence member of the human mitochondrial proteome.
    "We classified >8,000 proteins in mitochondrial preparations of human cells and defined a mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)."
The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination.
  • 3.0 A cryo-EM structure of ACAD9-ECSIT complex revealed a 15-residue ECSIT peptide (res 320-334) that inserts at the junction of ACAD9 dehydrogenase and vestigial domains. ECSIT binding induces a 10 A gatekeeper loop movement in ACAD9, releasing FAD. ECSIT phosphorylation downregulates its association with ACAD9 and is reduced upon amyloid-beta exposure.
    "ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor."
Reactome:R-HSA-6799179
Peripheral arm subunits bind the 815kDa complex to form a 980kDa complex
Reactome:R-HSA-6799196
The MCIA complex, NDUFAF2-7 all dissociate from the 980kDa complex, resulting in Complex I
Reactome:R-HSA-6799197
ND4, ND5 bind the 550kDa complex to form the 815kDa complex
Reactome:R-HSA-6799199
COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind the MCIA complex to form a 370kDa subcomplex
Reactome:R-HSA-6799202
The 315kDa subcomplex binds the 370kDa subcomplex to form the 550kDa complex

Suggested Questions for Experts

Q: What is the relative abundance of ACAD9 in its FAO (holo, FAD-bound) vs. CI assembly (apo, ECSIT-bound) states in different human tissues? Current understanding is based primarily on in vitro reconstitution, and the relative partitioning between FAO and assembly functions in vivo remains poorly quantified.

Q: Is there evidence that ACAD9 FAO function contributes to disease severity in ACAD9 deficiency, beyond the CI assembly defect? Schiff et al. 2015 suggested both CI assembly and FAO enzyme activity contribute to disease severity, but the relative contribution remains debated.

Suggested Experiments

Experiment: Quantitative proteomics to measure the fraction of ACAD9 in ECSIT-bound (assembly) vs. free (FAO-competent) states across human tissues, especially brain regions. This would clarify the in vivo partitioning of ACAD9 between its two mutually exclusive functions.

Deep Research

Falcon

(ACAD9-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 20 citations 2026-02-11T08:55:44.379720

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan and verification steps
- We verified the target: ACAD9 (HGNC:21497), UniProt Q9H845, a human mitochondrial acyl‑CoA dehydrogenase–family protein that functions as an essential Complex I (CI) assembly factor. Literature consistently identifies ACAD9 as a FAD‑binding homodimer paralogous to VLCAD that participates in CI biogenesis via the MCIA complex, confirming alignment with the UniProt description, domains, and family membership. No conflicting gene symbol usage was encountered in other organisms within the cited literature (all human-focused) (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 2-4, mcgregor2023theassemblyof pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).

Comprehensive research report
1) Key concepts and definitions (current understanding)
- Identity and dual function: ACAD9 is a FAD‑dependent acyl‑CoA dehydrogenase paralog that also serves as an essential assembly factor for mitochondrial Complex I (CI). As an enzyme, ACAD9 catalyzes the α,β‑dehydrogenation step of long‑chain fatty acyl‑CoA in fatty‑acid β‑oxidation (FAO). As an assembly factor, ACAD9 is a core member of the Mitochondrial Complex I Assembly (MCIA) complex, partnering with ECSIT and NDUFAF1 to build the ND2 membrane‑arm module of CI (functions are mutually exclusive; see below) (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 2-4, mcgregor2023theassemblyof pages 1-2).
- Primary role in vivo: Multiple genetic and cell‑biological studies indicate that ACAD9’s predominant physiological role is in CI biogenesis, with knockdown or mutation producing isolated CI deficiency and accumulation of defined assembly intermediates (nouws2013humanmitochondrialcomplex pages 70-73, schiff2015complexiassembly pages 1-2).

2) Molecular function and enzymatic activity (substrate specificity) versus assembly role
- Enzymatic activity: Purified human ACAD9 forms a FAD‑containing homodimer with measurable dehydrogenation activity toward long‑chain acyl‑CoA substrates; its catalytic rate is lower than VLCAD (~20% of VLCAD under comparable conditions). FAD binding stabilizes the ACAD9 dimer; the catalytic glutamate (E426) is essential for activity. ACAD9 exhibits sub‑stoichiometric FAD occupancy in vitro (~70%), and activity can be increased by adding FAD, reflecting relatively weak FAD binding in the apo state (xia2021molecularmechanismof pages 2-4, xia2021molecularmechanismof pages 13-14, xia2021molecularmechanismof pages 1-2).
- Assembly role via MCIA: ACAD9 forms the core MCIA ternary complex by binding ECSIT (ACAD9 N‑terminal domain to ECSIT C‑terminal domain) and NDUFAF1 (to ECSIT N‑terminal domain). This ternary complex is stable and required for assembly of ND2‑module intermediates of CI; loss of MCIA components causes specific CI assembly failure (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).
- Functional exclusivity and switching: Binding of ECSIT to ACAD9 triggers “deflavination” (loss of the FAD cofactor) and abrogates dehydrogenase activity, thereby switching ACAD9 from an FAO enzyme to a CI assembly factor. ECSIT and ETF (electron transfer flavoprotein) compete for overlapping sites on ACAD9’s N‑terminal region near FAD, mechanistically enforcing mutual exclusivity between FAO (ETF‑bound, FAD‑loaded) and assembly (ECSIT‑bound, deflavinated) states (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14, giachin2021assemblyofthe pages 3-4).

3) Subcellular localization, interacting partners, and structural mechanisms
- Localization: ACAD9 is a mitochondrial matrix‑facing homodimer associated with the inner membrane where CI is assembled (nouws2013humanmitochondrialcomplex pages 70-73).
- Interacting partners: Core MCIA partners include ECSIT and NDUFAF1; the MCIA functional module cooperates with TMEM126B/TMEM186 in ND2‑arm assembly. ETF interacts with ACAD9 in its enzymatic (FAO) state but is excluded by ECSIT during assembly (xia2021molecularmechanismof pages 2-4, xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14).
- Structural mechanism (deflavination): High‑resolution structural and biophysical work demonstrates that a C‑terminal ECSIT fragment binds ACAD9 and induces a conformational change in the FAD‑binding loop, causing FAD release (“deflavination”). Key interfacial residues include a salt bridge (ECSIT Glu323–ACAD9 Lys228) and a hydrogen bond (ECSIT Trp324–ACAD9 Ser191). ECSIT phosphorylation reduces ACAD9 binding; exposure of neuronal cells to amyloid‑β oligomers lowers ECSIT phosphorylation and promotes ECSIT–ACAD9 association, linking MCIA regulation to neurodegenerative stress (mcgregor2023theassemblyof pages 1-2, giachin2021assemblyofthe pages 3-4).

4) Disease associations and phenotypes
- Isolated Complex I deficiency: ACAD9 mutations produce isolated CI deficiency with phenotypes ranging from severe neonatal disease (metabolic acidosis, Leigh syndrome, hypertrophic cardiomyopathy) to later‑onset myopathy and multisystem involvement. Early multicenter cohorts demonstrated that ACAD9 loss compromises CI assembly and activity in patient cells and tissues (schiff2015complexiassembly pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Clinical spectrum and severity: A large compiled cohort of 70 ACAD9‑deficient patients reported high early mortality (>50% within the first year) among severe infantile cases; individuals with onset after 1 year of age had markedly better survival (>80%), often with riboflavin responsiveness (see below) (murgia2023newinsightsinto pages 9-11).
- Contribution of FAO impairment: Functional analyses of 16 ACAD9 variants from 24 patients support that both CI assembly failure and partial loss of ACAD enzymatic function correlate with disease severity; tissues with high ACAD9 expression (e.g., liver, neurons) may be more sensitive to its FAO role, complementing its obligatory assembly function (schiff2015complexiassembly pages 1-2).

5) Riboflavin (vitamin B2) responsiveness and therapeutic rationale
- Mechanistic rationale: As a FAD precursor, riboflavin may act as a chemical chaperone by improving FAD loading, folding, and stability of mutant ACAD9, partially restoring function. In vitro, excess FAD can restore dehydrogenase activity to ACAD9/ECSIT complexes, consistent with this model (xia2021molecularmechanismof pages 13-14).
- Clinical evidence: Cohort‑level data indicate that later‑onset ACAD9 deficiency often responds to riboflavin with improved outcomes, while severe neonatal cases show limited benefit. Individual patient fibroblast studies document increased CI activity (e.g., 1.7–2.1×) after riboflavin exposure, though not all genotypes respond (e.g., variants near the FAD pocket showed poor response in one case), underscoring genotype‑specific effects and the need for clinical monitoring (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).

6) Recent developments (prioritized 2023–2024)
- Structural basis of the switch to assembly: Nature Communications (2023) defined the ECSIT–ACAD9 interface that enforces deflavination and the functional switch to CI assembly; it also linked ECSIT phosphorylation dynamics to amyloid‑β exposure in neurons, suggesting stress‑regulated control of MCIA (mcgregor2023theassemblyof pages 1-2).
- Ongoing refinement of MCIA mechanisms: Contemporary structural/biophysical paradigms from 2021–2023 consolidate that MCIA relies on ECSIT as a bridging hub that binds ACAD9 C‑terminally and NDUFAF1 N‑terminally, rendering a stable complex that coordinates formation of ND2‑module intermediates and underscores the biochemical exclusivity between FAO and assembly states (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, giachin2021assemblyofthe pages 3-4, mcgregor2023theassemblyof pages 1-2).
- Translational perspective: A 2023 nutrition‑genomics review synthesizes cohort data on riboflavin‑responsive flavoprotein disorders including ACAD9, highlighting survival statistics, genotypic nuances, and proposing personalized riboflavin therapy frameworks for late‑onset cases (murgia2023newinsightsinto pages 9-11).

7) Current applications and real‑world implementations
- Diagnostics: Next‑generation sequencing for suspected mitochondrial disease frequently identifies ACAD9 variants; functional confirmation includes BN‑PAGE/enzymology for CI deficiency and, when feasible, FAO flux testing in tissues with higher ACAD9 expression. The dual role cautions that skin fibroblasts (low ACAD9) may under‑detect FAO defects, whereas HEK293 and high‑expression tissues better reveal enzymatic contributions (schiff2015complexiassembly pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Therapeutic approaches: Riboflavin supplementation is commonly attempted given its safety and potential benefit; responses should be tracked clinically and biochemically (e.g., lactate, exercise tolerance, CI activity), recognizing variability by genotype and age of onset (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).

8) Expert opinions and authoritative analyses
- Mechanistic consensus: ACAD9 is now broadly regarded as a moonlighting protein whose enzymatic FAO capacity is vestigial relative to VLCAD yet physiologically relevant in select tissues; its dominant essential role is as a CI assembly factor within MCIA. Deflavination triggered by ECSIT is the key structural‑biochemical switch between these roles (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, giachin2021assemblyofthe pages 3-4, mcgregor2023theassemblyof pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Clinical consensus: ACAD9 deficiency is a leading cause of nuclear‑encoded isolated CI deficiency, with cardiomyopathy common; riboflavin responsiveness is documented in many late‑onset cases though not uniform, and cohort data motivate genotype‑informed, monitored trials (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118, schiff2015complexiassembly pages 1-2).

9) Quantitative statistics and selected data
- Enzyme biochemistry: Purified ACAD9 dimer shows ~70% FAD occupancy; catalytic activity increases with exogenous FAD (half‑maximal stimulation ~0.75 mM FAD). Mutating the catalytic E426 abolishes activity, confirming canonical ACAD chemistry (xia2021molecularmechanismof pages 2-4).
- Assembly biochemistry: ECSIT binding to ACAD9 causes loss of FAD and dehydrogenase activity; ETF and ECSIT compete for overlapping binding surfaces near the N‑terminal/FAD region (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).
- Clinical cohorts: In a compiled 70‑patient ACAD9 cohort, >50% infant mortality within the first year in severe early‑onset disease; survival >80% in those with onset after 1 year, many of whom received riboflavin (murgia2023newinsightsinto pages 9-11).
- Functional variant testing: Across 16 ACAD9 variants from 24 patients, residual enzymatic activity inversely correlated with clinical severity, supporting a contributory FAO component in disease alongside the required CI assembly function (schiff2015complexiassembly pages 1-2).

10) Pathway placement and cellular site of action
- ACAD9’s assembly function operates at the matrix side of the inner mitochondrial membrane within the MCIA complex to guide ND2‑module formation and integration into CI. Its FAO enzyme function, when engaged, participates in mitochondrial long‑chain fatty‑acid β‑oxidation, transferring electrons to ETF; these two states are structurally incompatible due to ECSIT‑mediated deflavination and ETF competition (nouws2013humanmitochondrialcomplex pages 70-73, xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).

References with URLs and publication dates
- McGregor L, et al. The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination. Nature Communications. 2023-12. https://doi.org/10.1038/s41467-023-43865-0 (mcgregor2023theassemblyof pages 1-2)
- Xia C, et al. Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial respiratory complex I assembly. iScience. 2021-10. https://doi.org/10.1016/j.isci.2021.103153 (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14, xia2021molecularmechanismof pages 2-4)
- Giachin G, et al. Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for Deflavination. Angew Chem Int Ed. 2021-01. https://doi.org/10.1002/anie.202011548 (giachin2021assemblyofthe pages 3-4)
- Nouws J. Human mitochondrial complex I biogenesis: connections between mitochondrial translation, fatty acid oxidation and complex I assembly. Thesis/monograph. 2013. (contains experimental summaries cited above) (nouws2013humanmitochondrialcomplex pages 70-73, nouws2013humanmitochondrialcomplex pages 117-118)
- Schiff M, et al. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet. 2015-06. https://doi.org/10.1093/hmg/ddv074 (schiff2015complexiassembly pages 1-2)
- Murgia C, Dehlia A, Guthridge MA. New insights into the nutritional genomics of adult‑onset riboflavin‑responsive diseases. Nutr Metab (Lond). 2023-10. https://doi.org/10.1186/s12986-023-00764-x (murgia2023newinsightsinto pages 9-11)

Methodological notes and limitations
- While 2023–2024 sources substantially refine ACAD9’s structural switching and regulatory context (deflavination; ECSIT phosphorylation), large controlled treatment trials for riboflavin in ACAD9 deficiency remain limited. Reported cohort statistics come from compiled retrospective cohorts and reviews; genotype‑specific responsiveness should be interpreted cautiously and validated case‑by‑case (mcgregor2023theassemblyof pages 1-2, murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).

References

  1. (xia2021molecularmechanismof pages 1-2): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.

  2. (xia2021molecularmechanismof pages 14-16): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.

  3. (xia2021molecularmechanismof pages 2-4): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.

  4. (mcgregor2023theassemblyof pages 1-2): Lindsay McGregor, Samira Acajjaoui, Ambroise Desfosses, Melissa Saïdi, Maria Bacia-Verloop, Jennifer J. Schwarz, Pauline Juyoux, Jill von Velsen, Matthew W. Bowler, Andrew A. McCarthy, Eaazhisai Kandiah, Irina Gutsche, and Montserrat Soler-Lopez. The assembly of the mitochondrial complex i assembly complex uncovers a redox pathway coordination. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43865-0, doi:10.1038/s41467-023-43865-0. This article has 31 citations and is from a highest quality peer-reviewed journal.

  5. (nouws2013humanmitochondrialcomplex pages 70-73): J Nouws. Human mitochondrial complex i biogenesis. connections between mitochondrial translation, fatty acid oxidation and complex i assembly. Unknown journal, 2013.

  6. (schiff2015complexiassembly pages 1-2): Manuel Schiff, Birgit Haberberger, Chuanwu Xia, Al-Walid Mohsen, Eric S Goetzman, Yudong Wang, Radha Uppala, Yuxun Zhang, Anuradha Karunanidhi, Dolly Prabhu, Hana Alharbi, Edward V Prochownik, Tobias Haack, Johannes Häberle, Arnold Munnich, Agnes Rötig, Robert W Taylor, Robert D Nicholls, Jung-Ja Kim, Holger Prokisch, and Jerry Vockley. Complex i assembly function and fatty acid oxidation enzyme activity of acad9 both contribute to disease severity in acad9 deficiency. Human molecular genetics, 24 11:3238-47, Jun 2015. URL: https://doi.org/10.1093/hmg/ddv074, doi:10.1093/hmg/ddv074. This article has 78 citations and is from a domain leading peer-reviewed journal.

  7. (xia2021molecularmechanismof pages 13-14): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.

  8. (giachin2021assemblyofthe pages 3-4): Gabriele Giachin, Matthew Jessop, Romain Bouverot, Samira Acajjaoui, Melissa Saïdi, Anaïs Chretien, Maria Bacia‐Verloop, Luca Signor, Philippe J. Mas, Adrien Favier, Eve Borel Meneroud, Michael Hons, Darren J. Hart, Eaazhisai Kandiah, Elisabetta Boeri Erba, Alain Buisson, Gordon Leonard, Irina Gutsche, and Montserrat Soler‐Lopez. Assembly of the mitochondrial complex i assembly complex suggests a regulatory role for deflavination. Angewandte Chemie International Edition, 60:4689-4697, Jan 2021. URL: https://doi.org/10.1002/anie.202011548, doi:10.1002/anie.202011548. This article has 28 citations.

  9. (murgia2023newinsightsinto pages 9-11): Chiara Murgia, Ankush Dehlia, and Mark A. Guthridge. New insights into the nutritional genomics of adult-onset riboflavin-responsive diseases. Nutrition & Metabolism, Oct 2023. URL: https://doi.org/10.1186/s12986-023-00764-x, doi:10.1186/s12986-023-00764-x. This article has 17 citations and is from a peer-reviewed journal.

  10. (nouws2013humanmitochondrialcomplex pages 117-118): J Nouws. Human mitochondrial complex i biogenesis. connections between mitochondrial translation, fatty acid oxidation and complex i assembly. Unknown journal, 2013.

Citations

  1. nouws2013humanmitochondrialcomplex pages 70-73
  2. murgia2023newinsightsinto pages 9-11
  3. schiff2015complexiassembly pages 1-2
  4. xia2021molecularmechanismof pages 13-14
  5. mcgregor2023theassemblyof pages 1-2
  6. xia2021molecularmechanismof pages 2-4
  7. giachin2021assemblyofthe pages 3-4
  8. xia2021molecularmechanismof pages 1-2
  9. xia2021molecularmechanismof pages 14-16
  10. nouws2013humanmitochondrialcomplex pages 117-118
  11. https://doi.org/10.1038/s41467-023-43865-0
  12. https://doi.org/10.1016/j.isci.2021.103153
  13. https://doi.org/10.1002/anie.202011548
  14. https://doi.org/10.1093/hmg/ddv074
  15. https://doi.org/10.1186/s12986-023-00764-x
  16. https://doi.org/10.1016/j.isci.2021.103153,
  17. https://doi.org/10.1038/s41467-023-43865-0,
  18. https://doi.org/10.1093/hmg/ddv074,
  19. https://doi.org/10.1002/anie.202011548,
  20. https://doi.org/10.1186/s12986-023-00764-x,

📄 View Raw YAML

id: Q9H845
gene_symbol: ACAD9
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ACAD9 (Complex I assembly factor ACAD9, mitochondrial) is a dual-function protein that
  serves as both a mitochondrial respiratory chain Complex I (CI) assembly factor and an
  acyl-CoA dehydrogenase enzyme. Its primary physiological role is as a core component of
  the mitochondrial complex I intermediate assembly (MCIA) complex, where it partners with
  ECSIT and NDUFAF1 to mediate assembly of the ND2 membrane-arm module of CI. ECSIT binding
  triggers a conformational change and deflavination of ACAD9, switching it from an FAO enzyme
  to a CI assembly factor. As a secondary/moonlighting function, ACAD9 retains FAD-dependent
  acyl-CoA dehydrogenase activity toward long-chain (and some medium-chain) fatty acyl-CoA
  substrates (EC 1.3.8.7, 1.3.8.8), catalyzing the first step of mitochondrial fatty acid
  beta-oxidation. Disease-causing mutations in ACAD9 result in isolated CI deficiency (MC1DN20),
  not primary fatty acid oxidation defects, underscoring the primacy of its assembly role.
  ACAD9 is a homodimer localized to the matrix side of the mitochondrial inner membrane.
existing_annotations:
# --- Annotation 1: acyl-CoA dehydrogenase activity (IBA) ---
- term:
    id: GO:0003995
    label: acyl-CoA dehydrogenase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      ACAD9 is a bona fide acyl-CoA dehydrogenase, belonging to the ACAD family and retaining
      catalytic activity for the alpha,beta-dehydrogenation of fatty acyl-CoA substrates. The IBA
      annotation is phylogenetically inferred and well-supported by direct biochemical data from
      multiple publications (PMID:16020546, PMID:34646991, PMID:38086790). This is an appropriate
      level of specificity for the IBA evidence code.
    action: ACCEPT
    reason: >-
      ACAD9 has experimentally demonstrated acyl-CoA dehydrogenase activity. Purified ACAD9 shows
      dehydrogenation activity of 83 min-1 with palmitoyl-CoA as substrate (PMID:34646991). The
      IBA annotation at the general acyl-CoA dehydrogenase level is appropriate given phylogenetic
      support across the ACAD family.
    supported_by:
      - reference_id: PMID:34646991
        supporting_text: "As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein"
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 2: acyl-CoA dehydrogenase activity (IEA, InterPro) ---
- term:
    id: GO:0003995
    label: acyl-CoA dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation based on InterPro domain mapping. ACAD9 contains the acyl-CoA dehydrogenase
      active site signature (IPR006089) which correctly predicts this enzymatic activity. Consistent
      with direct experimental evidence.
    action: ACCEPT
    reason: >-
      The InterPro-based IEA annotation is correct and consistent with experimental data showing
      ACAD9 possesses acyl-CoA dehydrogenase activity (PMID:16020546, PMID:34646991). This is
      a broader annotation that is subsumed by the IBA and IDA annotations but not incorrect.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"

# --- Annotation 3: long-chain fatty acyl-CoA dehydrogenase activity (IEA, ARBA) ---
- term:
    id: GO:0004466
    label: long-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation from ARBA/Rhea mapping based on the EC 1.3.8.8 catalytic activity. ACAD9
      does have demonstrated long-chain acyl-CoA dehydrogenase activity (PMID:16020546), making
      this a valid annotation.
    action: ACCEPT
    reason: >-
      ACAD9 has experimentally demonstrated long-chain fatty acyl-CoA dehydrogenase activity
      with substrate preference for C16-C22 chain lengths (PMID:16020546). The IEA annotation
      correctly captures this function and is consistent with the IDA annotation from BHF-UCL.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 4: mitochondrial inner membrane (IEA, SubCell) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. ACAD9 is
      experimentally localized to the mitochondrial inner membrane, matrix side, as a peripheral
      membrane protein (PMID:16020546, PMID:20816094).
    action: ACCEPT
    reason: >-
      Multiple experimental studies confirm ACAD9 localizes to the mitochondrial inner membrane.
      Submitochondrial fractionation showed ACAD9 is membrane-associated (PMID:16020546). The
      UniProt entry explicitly states "Mitochondrion inner membrane; Peripheral membrane protein;
      Matrix side" with evidence from PMID:16020546 and PMID:20816094.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 5: fatty acid metabolic process (IEA, ARBA) ---
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA. ACAD9 participates in fatty acid beta-oxidation by catalyzing
      the first step of the FAO cycle. This is a broad term and while accurate, more specific
      terms (long-chain fatty acid metabolic process, GO:0001676) are already annotated.
    action: ACCEPT
    reason: >-
      ACAD9 does participate in fatty acid metabolism through its acyl-CoA dehydrogenase activity.
      While this IEA term is broader than the IDA annotation to GO:0001676, it is not incorrect
      and is an expected consequence of the ARBA mapping.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids"

# --- Annotation 6: oxidoreductase activity (IEA, KW) ---
- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA annotation based on UniProtKB keyword mapping (KW-0560, Oxidoreductase). ACAD9 is
      indeed an oxidoreductase. This is a very general term but is not incorrect for an IEA.
    action: ACCEPT
    reason: >-
      ACAD9 is an oxidoreductase (acyl-CoA dehydrogenase, EC 1.3.8.7/1.3.8.8). While this
      is a very broad parent term, it is correctly applied via keyword mapping and more specific
      child terms are also annotated.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"

# --- Annotation 7: oxidoreductase activity, acting on the CH-CH group of donors (IEA, InterPro) ---
- term:
    id: GO:0016627
    label: oxidoreductase activity, acting on the CH-CH group of donors
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation based on InterPro domain mapping. ACAD9 catalyzes alpha,beta-dehydrogenation
      of fatty acyl-CoA, which is an oxidoreductase reaction acting on CH-CH groups. This is a
      correct intermediate-level term between general oxidoreductase and specific acyl-CoA
      dehydrogenase activity.
    action: ACCEPT
    reason: >-
      The acyl-CoA dehydrogenase reaction catalyzed by ACAD9 involves oxidation of the CH-CH
      bond at the alpha-beta position of fatty acyl-CoA substrates. This InterPro-derived term
      is accurate and at an appropriate level of specificity for automated annotation.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"

# --- Annotation 8: mitochondrial membrane (IEA, ARBA) ---
- term:
    id: GO:0031966
    label: mitochondrial membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA. ACAD9 is localized to the mitochondrial inner membrane. This
      term is broader (parent) than the more specific mitochondrial inner membrane annotations
      also present, but is not incorrect.
    action: ACCEPT
    reason: >-
      ACAD9 is experimentally localized to the mitochondrial membrane (specifically the inner
      membrane). This broader IEA term is subsumed by more specific annotations but remains valid.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 9: flavin adenine dinucleotide binding (IEA, InterPro) ---
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation based on InterPro domain mapping. ACAD9 is a FAD-containing flavoprotein.
      FAD binding has been experimentally demonstrated, with approximately 70% FAD occupancy in
      purified protein (PMID:34646991). FAD binding is essential for the dehydrogenase function,
      and ECSIT binding causes deflavination (PMID:33320993, PMID:38086790).
    action: ACCEPT
    reason: >-
      ACAD9 binds FAD as a cofactor for its acyl-CoA dehydrogenase activity. The FAD content of
      purified ACAD9 is approximately 70% (PMID:34646991), and ECSIT-mediated deflavination
      switches ACAD9 from FAO enzyme to CI assembly factor (PMID:33320993).
    supported_by:
      - reference_id: PMID:34646991
        supporting_text: "the FAD content of purified wild type ACAD9 protein (non-tagged ACAD9 and ACAD9-His6) was approximately 70%"
      - reference_id: PMID:33320993
        supporting_text: "interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site"

# --- Annotation 10: medium-chain fatty acyl-CoA dehydrogenase activity (IEA, ARBA) ---
- term:
    id: GO:0070991
    label: medium-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation from ARBA/Rhea mapping based on EC 1.3.8.7. ACAD9 does have some activity
      toward medium-chain substrates (C9-C11-CoA) as demonstrated in PMID:16020546. However,
      its primary specificity is for long-chain substrates; medium-chain activity is lower and
      secondary.
    action: KEEP_AS_NON_CORE
    reason: >-
      While ACAD9 is primarily a long-chain ACAD, it does have experimentally demonstrated
      medium-chain activity (PMID:16020546), and this is consistent with the EC 1.3.8.7
      assignment in UniProt. The IEA annotation correctly reflects the catalogued EC number.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 11: very-long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:33320993) ---
- term:
    id: GO:0017099
    label: very-long-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:33320993
  review:
    summary: >-
      IDA annotation from FlyBase based on Giachin et al. 2021, which characterized ACAD9 acyl-CoA
      dehydrogenase activity using an ETF fluorescence reduction assay with palmitoyl-CoA (C16:0)
      as substrate. While ACAD9 does have dehydrogenase activity, the term "very-long-chain"
      (GO:0017099, typically C20+) may be an over-annotation. ACAD9's primary substrates are
      long-chain (C14-C18), not very-long-chain. The activity measured in this paper used
      palmitoyl-CoA (C16:0), which is a long-chain substrate.
    action: MODIFY
    reason: >-
      ACAD9 has optimal activity with long-chain (C14-C18) substrates, not very-long-chain (C20+).
      The paper PMID:33320993 demonstrated ACAD dehydrogenase activity using palmitoyl-CoA (C16:0),
      which is a long-chain substrate. While ACAD9 does have some activity on C20:0 (eicosanoyl-CoA)
      as shown in PMID:16020546, its primary specificity is long-chain. The annotation should be
      modified to long-chain fatty acyl-CoA dehydrogenase activity (GO:0004466).
    proposed_replacement_terms:
      - id: GO:0004466
        label: long-chain fatty acyl-CoA dehydrogenase activity
    supported_by:
      - reference_id: PMID:33320993
        supporting_text: "After addition of the ACAD specific substrate palmitoyl-CoA (C16:0), there is a clear loss of ETF fluorescence in ACAD9 alone"
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 12: very-long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:34646991) ---
- term:
    id: GO:0017099
    label: very-long-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:34646991
  review:
    summary: >-
      IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This paper characterized
      ACAD9 enzymatic activity using palmitoyl-CoA (C16:0) as substrate and measured dehydrogenation
      activity of 83 min-1. The activity is real but the term "very-long-chain" is an overstatement
      of specificity, since palmitoyl-CoA is a long-chain substrate.
    action: MODIFY
    reason: >-
      Same reasoning as above. ACAD9 has its optimal activity on long-chain substrates (C14-C18).
      The paper PMID:34646991 used palmitoyl-CoA (C16:0) as substrate, which is long-chain.
      The VLCAD-like annotation is misleading; ACAD9 activity is only 18% of VLCAD activity
      (PMID:34646991).
    proposed_replacement_terms:
      - id: GO:0004466
        label: long-chain fatty acyl-CoA dehydrogenase activity
    supported_by:
      - reference_id: PMID:34646991
        supporting_text: "this activity is only 18% of VLCAD activity"
      - reference_id: PMID:34646991
        supporting_text: "As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein"

# --- Annotation 13: protein-macromolecule adaptor activity (IDA, PMID:32320651) ---
- term:
    id: GO:0030674
    label: protein-macromolecule adaptor activity
  evidence_type: IDA
  original_reference_id: PMID:32320651
  review:
    summary: >-
      IDA annotation from FlyBase based on Formosa et al. 2020, which demonstrated that ACAD9
      is a core component of the MCIA complex and acts as an adaptor linking ECSIT (and through it,
      NDUFAF1) to CI assembly intermediates. The study showed ACAD9 forms a hierarchy of stability
      centered on itself within the MCIA complex. This is an excellent annotation capturing ACAD9's
      primary assembly factor role using a molecular function term.
    action: ACCEPT
    reason: >-
      ACAD9 functions as a protein-macromolecule adaptor within the MCIA complex, bridging ECSIT
      to CI assembly intermediates. This is well-supported by PMID:32320651, which showed that
      knockout of ACAD9 destabilizes the entire MCIA complex, and by structural studies showing
      ACAD9 provides binding surfaces for ECSIT via its vestigial dehydrogenase domain
      (PMID:33320993, PMID:38086790). This annotation captures the core molecular function of
      ACAD9 in CI assembly.
    supported_by:
      - reference_id: PMID:32320651
        supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"
      - reference_id: PMID:33320993
        supporting_text: "ECSIT functions as the bridging node of the MCIA core complex"

# --- Annotation 14: mitochondrial complex I intermediate assembly complex (IDA, PMID:33320993) ---
- term:
    id: GO:0160295
    label: mitochondrial complex I intermediate assembly complex
  evidence_type: IDA
  original_reference_id: PMID:33320993
  review:
    summary: >-
      IDA annotation from FlyBase based on Giachin et al. 2021. This study provided extensive
      structural and biochemical evidence that ACAD9 is a core component of the MCIA complex,
      including cryo-EM structures, SAXS, native MS, and SEC-MALLS data demonstrating stable
      ACAD9-ECSIT complexes.
    action: ACCEPT
    reason: >-
      ACAD9 is unequivocally a component of the MCIA complex. Giachin et al. demonstrated
      formation of the ACAD9-ECSIT binary complex by multiple biophysical methods and showed
      ECSIT binds the vestigial dehydrogenase domain of ACAD9 (PMID:33320993). This is a core
      annotation for ACAD9.
    supported_by:
      - reference_id: PMID:33320993
        supporting_text: "ECSIT functions as the bridging node of the MCIA core complex"
      - reference_id: PMID:33320993
        supporting_text: "the C-terminal domain of ECSIT directly binds to the vestigial dehydrogenase domain of the FAO enzyme ACAD9 and induces its deflavination"

# --- Annotation 15: mitochondrial complex I intermediate assembly complex (IDA, PMID:34646991) ---
- term:
    id: GO:0160295
    label: mitochondrial complex I intermediate assembly complex
  evidence_type: IDA
  original_reference_id: PMID:34646991
  review:
    summary: >-
      IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This study reconstituted
      the ACAD9/ECSIT/NDUFAF1 ternary complex in vitro and characterized it by SEC, SAXS, and
      pull-down assays, demonstrating ACAD9 is a core member of the MCIA complex.
    action: ACCEPT
    reason: >-
      Xia et al. provided direct biochemical evidence for ACAD9 as part of the MCIA ternary
      complex with ECSIT and NDUFAF1, including purification of the stable ternary complex with
      1:1:1 stoichiometry (PMID:34646991). This is strong supporting evidence for the CC annotation.
    supported_by:
      - reference_id: PMID:34646991
        supporting_text: "ACAD9, ECSIT, and NDUFAF1 form the core mitochondrial CI assembly (MCIA) complex"
      - reference_id: PMID:34646991
        supporting_text: "mixing of the three purified, individual proteins forms a ternary complex, ACAD9/ECSIT/NDUFAF1, with a 1:1:1 molar (monomer) ratio"

# --- Annotation 16: mitochondrion (IDA, GO_REF:0000052, HPA) ---
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >-
      IDA annotation from HPA based on immunofluorescence data. ACAD9 localization to
      mitochondria is well-established across multiple studies and methods.
    action: ACCEPT
    reason: >-
      ACAD9 mitochondrial localization is confirmed by multiple independent approaches:
      submitochondrial fractionation (PMID:16020546), immunofluorescence (PMID:20816094),
      and proteomics (PMID:34800366). The HPA immunofluorescence data is consistent with
      this body of evidence.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 17: mitochondrial complex I intermediate assembly complex (IDA, PMID:32320651) ---
- term:
    id: GO:0160295
    label: mitochondrial complex I intermediate assembly complex
  evidence_type: IDA
  original_reference_id: PMID:32320651
  review:
    summary: >-
      IDA annotation from FlyBase based on Formosa et al. 2020. This study used cell knockout
      studies of each MCIA component and demonstrated that ACAD9 is central to MCIA complex
      stability, also identifying TMEM186 and COA1 as additional MCIA components.
    action: ACCEPT
    reason: >-
      Formosa et al. provided strong genetic evidence from knockout studies that ACAD9 is a
      core component of the MCIA complex, with a central role in maintaining complex stability.
      Loss of ACAD9 resulted in destabilization of the entire MCIA complex and impaired CI
      assembly (PMID:32320651).
    supported_by:
      - reference_id: PMID:32320651
        supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
      - reference_id: PMID:32320651
        supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"

# --- Annotation 18: acyl-CoA dehydrogenase activity (IDA, PMID:38086790) ---
- term:
    id: GO:0003995
    label: acyl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:38086790
  review:
    summary: >-
      IDA annotation from FlyBase based on McGregor et al. 2023 (Nature Communications). This
      study determined a 3.0 A cryo-EM structure of the ACAD9-ECSIT complex and also characterized
      ACAD9 dehydrogenase activity using the ETF fluorescence reduction assay with palmitoyl-CoA.
      The study demonstrated ECSIT binding induces a large conformational change in the FAD-binding
      loop of ACAD9, releasing FAD and converting ACAD9 from an FAO enzyme to a CI assembly factor.
    action: ACCEPT
    reason: >-
      McGregor et al. directly measured ACAD9 acyl-CoA dehydrogenase activity via ETF fluorescence
      reduction assay and confirmed the deflavination mechanism (PMID:38086790). This provides
      direct experimental evidence for ACAD9's enzymatic function.
    supported_by:
      - reference_id: PMID:38086790
        supporting_text: "ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor"

# --- Annotation 19: mitochondrial inner membrane (NAS, PMID:32320651) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: NAS
  original_reference_id: PMID:32320651
  review:
    summary: >-
      NAS annotation from ComplexPortal based on PMID:32320651. ACAD9 functions as part of the
      MCIA complex at the mitochondrial inner membrane where CI assembly occurs. This is
      consistent with the experimentally determined localization.
    action: ACCEPT
    reason: >-
      ACAD9 is localized to the mitochondrial inner membrane, matrix side, as a peripheral
      membrane protein. This is well-supported by fractionation studies (PMID:16020546) and
      is the site of its CI assembly function as part of the MCIA complex (PMID:32320651).
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 20: mitochondrial respiratory chain complex I assembly (NAS, PMID:32320651) ---
- term:
    id: GO:0032981
    label: mitochondrial respiratory chain complex I assembly
  evidence_type: NAS
  original_reference_id: PMID:32320651
  review:
    summary: >-
      NAS annotation from ComplexPortal based on Formosa et al. 2020. ACAD9 is essential for
      CI assembly as a core member of the MCIA complex. This is the primary biological process
      annotation for ACAD9 and represents its most important physiological function.
    action: ACCEPT
    reason: >-
      CI assembly is the primary biological process function of ACAD9. Multiple studies demonstrate
      that loss of ACAD9 causes isolated CI deficiency (PMID:20816094), ACAD9 is part of the
      MCIA complex required for ND2-module assembly (PMID:32320651), and disease mutations
      cluster in the assembly domain (PMID:20816094).
    additional_reference_ids:
      - file:human/ACAD9/ACAD9-deep-research-falcon.md
    supported_by:
      - reference_id: PMID:32320651
        supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
      - reference_id: file:human/ACAD9/ACAD9-deep-research-falcon.md
        supporting_text: "its dominant essential role is as a CI assembly factor within MCIA."

# --- Annotation 21: mitochondrion (HTP, PMID:34800366) ---
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  review:
    summary: >-
      HTP annotation from high-throughput human mitochondrial proteome study (Morgenstern et al.
      2021). ACAD9 was identified as a high-confidence mitochondrial protein. This is consistent
      with extensive prior evidence.
    action: ACCEPT
    reason: >-
      ACAD9 is a well-established mitochondrial protein. Its identification in a quantitative
      high-confidence mitochondrial proteome study (PMID:34800366) adds further confirmation
      to established knowledge from targeted studies (PMID:16020546, PMID:20816094).
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 22: protein binding (IPI, PMID:33753518) ---
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33753518
  review:
    summary: >-
      IPI annotation based on Carroll et al. 2021, which showed TMEM70 and TMEM242 interact
      with MCIA complex components including ACAD9. The WITH field includes UniProtKB:Q8IUX1
      (TMEM242), Q9BQ95 (TMEM126B), Q9BUB7 (TMEM70), and Q9Y375 (NDUFAF1). While the
      interactions are real and informative, the term 'protein binding' is uninformative.
      The adaptor activity annotation (GO:0030674) already captures the functionally relevant
      aspect.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The protein binding term is uninformative. The ACAD9 interactions with TMEM70 and TMEM242
      are real (PMID:33753518), but this function is better captured by the protein-macromolecule
      adaptor activity annotation (GO:0030674) and the MCIA complex membership (GO:0160295).
      Generic 'protein binding' does not tell us anything about the actual function of ACAD9.
    supported_by:
      - reference_id: PMID:33753518
        supporting_text: "TMEM70 and TMEM242 interact with the mitochondrial complex I assembly (the MCIA) complex that supports assembly of the membrane arm of complex I"

# --- Annotation 23: protein binding (IPI, PMID:32320651) ---
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32320651
  review:
    summary: >-
      IPI annotation based on Formosa et al. 2020. The WITH field includes TMEM126B (Q96B77),
      ECSIT (Q9BQ95), TMEM186 (Q9GZY4), and NDUFAF1 (Q9Y375). These are the MCIA complex
      interactions. While real, 'protein binding' is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Same as above. The interactions with MCIA complex components are real and well-characterized
      (PMID:32320651), but 'protein binding' is uninformative. The adaptor activity (GO:0030674)
      and MCIA complex membership (GO:0160295) annotations are more informative.
    supported_by:
      - reference_id: PMID:32320651
        supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"

# --- Annotation 24: long-chain fatty acid metabolic process (IDA, PMID:16020546) ---
- term:
    id: GO:0001676
    label: long-chain fatty acid metabolic process
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 participates in
      long-chain fatty acid beta-oxidation, with maximal activity toward long-chain unsaturated
      acyl-CoA substrates (C16:1, C18:1, C18:2, C22:6). This is a secondary/moonlighting
      function but is experimentally well-supported.
    action: KEEP_AS_NON_CORE
    reason: >-
      While ACAD9 does participate in long-chain fatty acid metabolism, this represents a
      secondary/moonlighting function. The primary in vivo role is CI assembly (PMID:20816094).
      Disease mutations cause CI deficiency rather than primary FAO defects (PMID:20816094).
      However, FAO activity is tissue-relevant especially in brain where ACAD9 is the main
      long-chain ACAD (PMID:16020546, PMID:17564966).
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation"

# --- Annotation 25: long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:16020546) ---
- term:
    id: GO:0004466
    label: long-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 was purified, expressed,
      and its substrate utilization pattern characterized, demonstrating maximal activity with
      long-chain (C16-C18) unsaturated acyl-CoA substrates. This is the most appropriate
      specific MF term for ACAD9's enzymatic activity.
    action: ACCEPT
    reason: >-
      ACAD9 has well-characterized long-chain acyl-CoA dehydrogenase activity with Km values
      of 2.8 uM for hexadecanoyl-CoA and 0.7 uM for (9Z)-hexadecenoyl-CoA (PMID:16020546).
      This is the correct level of specificity for ACAD9's enzymatic function.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 26: mitochondrion (IDA, PMID:16020546) ---
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation
      studies confirmed ACAD9 is associated with the mitochondrial membrane.
    action: ACCEPT
    reason: >-
      Direct experimental evidence from submitochondrial fractionation demonstrates ACAD9
      is a mitochondrial protein associated with mitochondrial membranes (PMID:16020546).
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 27: mitochondrial membrane (IDA, PMID:16020546) ---
- term:
    id: GO:0031966
    label: mitochondrial membrane
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation
      showed ACAD9 is membrane-associated. This is less specific than the inner membrane annotation
      but still correct based on the fractionation data.
    action: ACCEPT
    reason: >-
      ACAD9 is a peripheral membrane protein associated with the mitochondrial inner membrane
      on the matrix side (PMID:16020546). The mitochondrial membrane annotation is correct,
      though the more specific inner membrane annotation is also present.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 28: medium-chain fatty acid metabolic process (IDA, PMID:16020546) ---
- term:
    id: GO:0051791
    label: medium-chain fatty acid metabolic process
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows some activity
      toward medium-chain substrates (C9-C11-CoA) in addition to its primary long-chain
      specificity. This is a secondary activity.
    action: KEEP_AS_NON_CORE
    reason: >-
      ACAD9 does have some medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), but
      its primary enzymatic specificity is for long-chain substrates, and its primary biological
      role is CI assembly. Medium-chain FAO is a minor secondary activity, better handled by
      MCAD in vivo.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 29: medium-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:16020546) ---
- term:
    id: GO:0070991
    label: medium-chain fatty acyl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows activity toward
      some medium-chain substrates in the C9-C11 range. While less active than on long-chain
      substrates, this has been directly demonstrated experimentally.
    action: KEEP_AS_NON_CORE
    reason: >-
      ACAD9 does have demonstrable medium-chain acyl-CoA dehydrogenase activity (PMID:16020546),
      though this is secondary to its long-chain specificity and far secondary to its CI assembly
      role. The activity is real but minor compared to dedicated MCAD.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"

# --- Annotation 30: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799179) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6799179
  review:
    summary: >-
      TAS annotation from Reactome pathway "Peripheral arm subunits bind the 815kDa complex to
      form a 980kDa complex". ACAD9 functions at the mitochondrial inner membrane as part of the
      MCIA complex during CI biogenesis.
    action: ACCEPT
    reason: >-
      ACAD9 is localized to the mitochondrial inner membrane where CI assembly takes place.
      This is well-supported experimentally (PMID:16020546, PMID:20816094) and the Reactome
      annotation correctly reflects this.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 31: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799196) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6799196
  review:
    summary: >-
      TAS annotation from Reactome pathway "The MCIA complex, NDUFAF2-7 all dissociate from the
      980kDa complex, resulting in Complex I". Consistent with ACAD9's role as an MCIA assembly
      factor at the inner membrane.
    action: ACCEPT
    reason: >-
      Same as above. ACAD9 is at the mitochondrial inner membrane and this Reactome step
      describes MCIA complex dissociation after CI assembly is complete. Well-supported
      experimentally.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 32: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799197) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6799197
  review:
    summary: >-
      TAS annotation from Reactome pathway "ND4, ND5 bind the 550kDa complex to form the 815kDa
      complex". Another step in CI biogenesis at the inner membrane.
    action: ACCEPT
    reason: >-
      Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 33: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799199) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6799199
  review:
    summary: >-
      TAS annotation from Reactome pathway "COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind
      the MCIA complex to form a 370kDa subcomplex". This step directly involves the MCIA complex
      of which ACAD9 is a core member.
    action: ACCEPT
    reason: >-
      ACAD9 is a core member of the MCIA complex that participates in this assembly step.
      Well-supported by PMID:32320651.
    supported_by:
      - reference_id: PMID:32320651
        supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"

# --- Annotation 34: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799202) ---
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6799202
  review:
    summary: >-
      TAS annotation from Reactome pathway "The 315kDa subcomplex binds the 370kDa subcomplex
      to form the 550kDa complex". Another CI assembly step at the inner membrane.
    action: ACCEPT
    reason: >-
      Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 35: protein binding (IPI, PMID:20816094) ---
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20816094
  review:
    summary: >-
      IPI annotation based on Nouws et al. 2010, which showed ACAD9 interacts with NDUFAF1
      (Q9Y375) and ECSIT (Q9BQ95). These are the foundational interactions establishing ACAD9
      as an MCIA complex member. However, 'protein binding' is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The interactions demonstrated by Nouws et al. (PMID:20816094) are central to understanding
      ACAD9's CI assembly function, but the generic 'protein binding' term fails to capture the
      biological significance. The adaptor activity (GO:0030674) and MCIA complex membership
      (GO:0160295) annotations are far more informative.
    supported_by:
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"

# --- Annotation 36: mitochondrion (IDA, PMID:20816094) ---
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:20816094
  review:
    summary: >-
      IDA annotation based on Nouws et al. 2010. ACAD9 was shown to localize to mitochondria
      as part of the study establishing its role in CI assembly.
    action: ACCEPT
    reason: >-
      ACAD9 mitochondrial localization is well-established and confirmed in this study
      (PMID:20816094) which demonstrated ACAD9 interactions with mitochondrial CI assembly
      factors.
    supported_by:
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"

# --- Annotation 37: mitochondrial respiratory chain complex I assembly (IMP, PMID:20816094) ---
- term:
    id: GO:0032981
    label: mitochondrial respiratory chain complex I assembly
  evidence_type: IMP
  original_reference_id: PMID:20816094
  review:
    summary: >-
      IMP annotation based on Nouws et al. 2010. This landmark study demonstrated that ACAD9
      mutations result in CI deficiency (not FAO deficiency), establishing CI assembly as ACAD9's
      primary function. ACAD9 knockdown/mutation leads to impaired CI assembly. This is the
      strongest evidence for ACAD9's primary biological process.
    action: ACCEPT
    reason: >-
      Nouws et al. provided the foundational evidence that ACAD9 is required for CI biogenesis,
      showing that ACAD9 mutations cause CI deficiency rather than FAO defects, and that ACAD9
      interacts with known CI assembly factors NDUFAF1 and ECSIT (PMID:20816094). This IMP
      annotation is the most critical biological process annotation for ACAD9.
    supported_by:
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
      - reference_id: PMID:20816094
        supporting_text: "ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation"

# --- Annotation 38: nucleus (IDA, PMID:21237683) ---
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:21237683
  review:
    summary: >-
      IDA annotation based on He et al. 2011. This study characterized new long-chain ACADs
      including ACAD9, ACAD10, and ACAD11, and reported ACAD9 in the nucleus. However, ACAD9
      is a mitochondrial protein with a mitochondrial transit peptide, and all functional studies
      place it in mitochondria. Nuclear localization is likely an artifact of overexpression or
      immunostaining cross-reactivity and is not supported by the consensus of literature.
    action: REMOVE
    reason: >-
      ACAD9 has a mitochondrial transit peptide (residues 1-37, cleaved upon import; PMID:16020546)
      and all functional characterization places it in mitochondria. The nuclear localization
      reported in PMID:21237683 is not supported by other studies and is likely artifactual.
      UniProt does not include nuclear localization. The extensive proteomics and fractionation
      data consistently place ACAD9 in mitochondria only.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "A 37-amino acid leader peptide was cleaved sequentially by two mitochondrial peptidases to yield a predicted molecular mass of 65 kDa for the mature subunit"

# --- Annotation 39: dendrite (IDA, PMID:21237683) ---
- term:
    id: GO:0030425
    label: dendrite
  evidence_type: IDA
  original_reference_id: PMID:21237683
  review:
    summary: >-
      IDA annotation based on He et al. 2011. The study examined ACAD expression patterns in
      human cerebellum and found ACAD9 was highly expressed in the granular layer. The dendrite
      annotation likely reflects immunohistochemical staining of neuronal processes. However,
      this is a cell-type expression pattern rather than a specific subcellular localization
      to dendrites. The protein within those cells is still in mitochondria.
    action: REMOVE
    reason: >-
      ACAD9 is a mitochondrial matrix-facing protein. Finding it in neurons (including dendritic
      processes) reflects tissue expression (ACAD9 is highly expressed in cerebellum) rather than
      specific dendritic localization. The protein is in mitochondria within dendrites, not in
      the dendritic cytoplasm. This annotation conflates cell-type expression with subcellular
      localization.
    supported_by:
      - reference_id: PMID:21237683
        supporting_text: "ACAD9 was most highly expressed in the granular layer"
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- Annotation 40: mitochondrion (IDA, GO_REF:0000054, LIFEdb) ---
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000054
  review:
    summary: >-
      IDA annotation from LIFEdb based on expressed fusion protein localization in living cells.
      ACAD9 localization to mitochondria was confirmed, consistent with all other evidence.
    action: ACCEPT
    reason: >-
      ACAD9 mitochondrial localization is well-established. The LIFEdb fusion protein experiment
      confirms what is known from multiple other approaches (PMID:16020546, PMID:20816094,
      PMID:34800366).
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"

# --- NEW annotations not currently in GOA ---
# --- Annotation 41: NEW - fatty acid beta-oxidation (BP) ---
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IDA
  original_reference_id: PMID:16020546
  review:
    summary: >-
      ACAD9 catalyzes the first step of mitochondrial fatty acid beta-oxidation, the
      alpha,beta-dehydrogenation of long-chain fatty acyl-CoA substrates. This specific
      biological process term is not currently annotated but is more precise than the existing
      GO:0006631 (fatty acid metabolic process) and GO:0001676 (long-chain fatty acid metabolic
      process) annotations.
    action: NEW
    reason: >-
      ACAD9 directly catalyzes the first step of the beta-oxidation cycle. The existing BP
      annotations (GO:0006631 fatty acid metabolic process, GO:0001676 long-chain fatty acid
      metabolic process) are correct but the more specific fatty acid beta-oxidation term is
      warranted given the direct experimental evidence. This is ACAD9's secondary core function.
    supported_by:
      - reference_id: PMID:16020546
        supporting_text: "Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids"
      - reference_id: PMID:34646991
        supporting_text: "ACAD9 was first identified as a member of the acyl-CoA dehydrogenase family catalyzing the alpha, beta-dehydrogenation of fatty acyl-CoA thioesters, the first step of the fatty acid beta-oxidation cycle"

core_functions:
- molecular_function:
    id: GO:0030674
    label: protein-macromolecule adaptor activity
  directly_involved_in:
  - id: GO:0032981
    label: mitochondrial respiratory chain complex I assembly
  locations:
  - id: GO:0005743
    label: mitochondrial inner membrane
  in_complex:
    id: GO:0160295
    label: mitochondrial complex I intermediate assembly complex
  description: >-
    Primary function. ACAD9 is a core component of the MCIA complex, functioning as a
    protein-macromolecule adaptor that bridges ECSIT (and through ECSIT, NDUFAF1) to CI assembly
    intermediates. ECSIT binding triggers deflavination and a conformational switch from FAO enzyme
    to assembly factor. Disease mutations causing CI deficiency (MC1DN20) underscore this as the
    essential role.
  supported_by:
  - reference_id: PMID:20816094
    supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
  - reference_id: PMID:32320651
    supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"
  - reference_id: PMID:38086790
    supporting_text: "ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor"

- molecular_function:
    id: GO:0004466
    label: long-chain fatty acyl-CoA dehydrogenase activity
  directly_involved_in:
  - id: GO:0006635
    label: fatty acid beta-oxidation
  locations:
  - id: GO:0005743
    label: mitochondrial inner membrane
  description: >-
    Secondary/moonlighting function. ACAD9 retains FAD-dependent acyl-CoA dehydrogenase activity
    (EC 1.3.8.8) toward long-chain fatty acyl-CoA substrates, catalyzing the first step of
    mitochondrial fatty acid beta-oxidation. Its activity is approximately 18% that of VLCAD. This
    function is mutually exclusive with the CI assembly role (ECSIT binding causes deflavination).
    ACAD9's FAO role is particularly relevant in tissues where it is the main long-chain ACAD, such
    as the CNS.
  supported_by:
  - reference_id: PMID:16020546
    supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
  - reference_id: PMID:34646991
    supporting_text: "this activity is only 18% of VLCAD activity"

proposed_new_terms: []

suggested_questions:
- question: >-
    What is the relative abundance of ACAD9 in its FAO (holo, FAD-bound) vs. CI assembly
    (apo, ECSIT-bound) states in different human tissues? Current understanding is based
    primarily on in vitro reconstitution, and the relative partitioning between FAO and
    assembly functions in vivo remains poorly quantified.

- question: >-
    Is there evidence that ACAD9 FAO function contributes to disease severity in ACAD9
    deficiency, beyond the CI assembly defect? Schiff et al. 2015 suggested both CI assembly
    and FAO enzyme activity contribute to disease severity, but the relative contribution
    remains debated.

suggested_experiments:
- description: >-
    Quantitative proteomics to measure the fraction of ACAD9 in ECSIT-bound (assembly) vs.
    free (FAO-competent) states across human tissues, especially brain regions. This would
    clarify the in vivo partitioning of ACAD9 between its two mutually exclusive functions.

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: >-
    Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
    mapping, accompanied by conservative changes to GO terms applied by UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000054
  title: >-
    Gene Ontology annotation based on curation of intracellular localizations of expressed
    fusion proteins in living cells
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:16020546
  title: >-
    Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation
    of unsaturated fatty acids.
  findings:
    - statement: >-
        ACAD9 is a mitochondrial membrane-associated homodimer with long-chain acyl-CoA
        dehydrogenase activity, maximal toward unsaturated C16-C22 substrates.
      supporting_text: >-
        Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs
        as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA).
- id: PMID:20816094
  title: >-
    Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation
    complex I.
  findings:
    - statement: >-
        ACAD9 binds CI assembly factors NDUFAF1 and ECSIT and is specifically required for CI
        assembly. ACAD9 mutations cause CI deficiency, not FAO defects.
      supporting_text: >-
        ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required
        for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I
        deficiency and not in disturbed long-chain fatty acid oxidation.
- id: PMID:21237683
  title: Identification and characterization of new long chain acyl-CoA dehydrogenases.
  findings:
    - statement: >-
        ACAD9 is highly expressed in human cerebellum (granular layer), where ACADV is not found,
        suggesting tissue-specific roles in long-chain FAO.
      supporting_text: >-
        ACAD9 was most highly expressed in the granular layer, ACAD11 in the white matter,
        and MCAD in the molecular layer and axons of specific neurons.
- id: PMID:24158852
  title: >-
    ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation
    deficiencies.
  findings:
    - statement: >-
        The CI assembly function of ACAD9 is independent of its FAO activity. The E426Q catalytic
        mutant abolishes dehydrogenase activity but does not affect CI assembly.
      supporting_text: >-
        Catalytically inactive ACAD9 gave partial-to-complete rescue of complex I
        biogenesis in ACAD9-deficient cells
- id: PMID:32320651
  title: >-
    Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly Complex Factors in
    the Biogenesis of Complex I.
  findings:
    - statement: >-
        ACAD9 is a core member of the MCIA complex (with NDUFAF1, ECSIT, TMEM126B) required for
        ND2-module assembly. A hierarchy of stability exists centered on ACAD9. TMEM186 and COA1
        are additional MCIA components.
      supporting_text: >-
        while each MCIA component is critical for complex I assembly, a hierarchy of stability
        exists centered on ACAD9.
- id: PMID:33320993
  title: >-
    Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for
    Deflavination.
  findings:
    - statement: >-
        ECSIT C-terminal domain binds the vestigial dehydrogenase domain of ACAD9 and induces
        deflavination, switching ACAD9 from an FAO enzyme to a CI assembly factor. Cryo-EM
        confirmed the FAD binding site is empty in the ECSIT-bound state.
      supporting_text: >-
        interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site.
- id: PMID:33753518
  title: >-
    TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase and interact
    with assembly factors for complex I.
  findings:
    - statement: >-
        TMEM70 and TMEM242 interact with MCIA complex components including ACAD9, ECSIT,
        NDUFAF1, and TMEM126B.
      supporting_text: >-
        When TMEM242-t and similarly tagged TMEM70 (TMEM70-t) were expressed separately in
        HEK293 cells, the most significantly associated proteins were ACAD9 (acyl-CoA
        dehydrogenase family member 9), ECSIT (evolutionarily conserved signaling intermediate
        in Toll pathway), and NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1)
- id: PMID:34646991
  title: >-
    Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial
    respiratory complex I assembly.
  findings:
    - statement: >-
        ACAD9, ECSIT, and NDUFAF1 form a stable 1:1:1 ternary complex. ECSIT binds at the ETF
        binding site in ACAD9's N-terminal domain, explaining the mutual exclusivity of FAO and
        assembly functions. ACAD9 activity is only 18% of VLCAD.
      supporting_text: >-
        this activity is only 18% of VLCAD activity
- id: PMID:34800366
  title: >-
    Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular
    context.
  findings:
    - statement: >-
        ACAD9 was identified as a high-confidence member of the human mitochondrial proteome.
      supporting_text: >-
        We classified >8,000 proteins in mitochondrial preparations of human cells and
        defined a mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP).
- id: PMID:38086790
  title: >-
    The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway
    coordination.
  findings:
    - statement: >-
        3.0 A cryo-EM structure of ACAD9-ECSIT complex revealed a 15-residue ECSIT peptide
        (res 320-334) that inserts at the junction of ACAD9 dehydrogenase and vestigial domains.
        ECSIT binding induces a 10 A gatekeeper loop movement in ACAD9, releasing FAD. ECSIT
        phosphorylation downregulates its association with ACAD9 and is reduced upon amyloid-beta
        exposure.
      supporting_text: >-
        ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9,
        releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO)
        enzyme to a CI assembly factor.
- id: Reactome:R-HSA-6799179
  title: Peripheral arm subunits bind the 815kDa complex to form a 980kDa complex
  findings: []
- id: Reactome:R-HSA-6799196
  title: >-
    The MCIA complex, NDUFAF2-7 all dissociate from the 980kDa complex, resulting in Complex I
  findings: []
- id: Reactome:R-HSA-6799197
  title: ND4, ND5 bind the 550kDa complex to form the 815kDa complex
  findings: []
- id: Reactome:R-HSA-6799199
  title: >-
    COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind the MCIA complex to form a 370kDa
    subcomplex
  findings: []
- id: Reactome:R-HSA-6799202
  title: The 315kDa subcomplex binds the 370kDa subcomplex to form the 550kDa complex
  findings: []